{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T14:27:01Z","timestamp":1789223221185,"version":"build-2803163510"},"reference-count":44,"publisher":"American Chemical Society (ACS)","issue":"31","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023MH318"],"award-info":[{"award-number":["ZR2023MH318"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Atherosclerosis (AS) is a progressive cardiovascular disease characterized by arterial plaque formation, macrophage-driven inflammation, and excessive accumulation of reactive oxygen species (ROS). However, current clinical interventions remain limited by restenosis and thrombosis, while conventional pharmacotherapies suffer from poor bioavailability and off-target toxicity, highlighting the urgent need for more effective and targeted therapeutic strategies. To address the need for precise intervention, we engineered a multifunctional liposomal platform (Rh-ManLP@Ce) designed to synergize active targeting capabilities with environment-responsive payload release. Central to this design is the synthesis of DSPE-PEG-Rhein, a modification that not only significantly improves the solubility and stability of Rhein but also enables its seamless integration into the lipid bilayer, serving simultaneously as a structural element and a therapeutic agent. By incorporating ROS-responsive lipids into this carrier backbone, the system is programmed to undergo rapid structural disassembly solely within the high-ROS plaque microenvironment, ensuring drug release is strictly triggered by local pathological conditions. Further refining its specificity, the liposome surface is decorated with mannose ligands to actively target macrophage mannose receptors, culminating in the construction of the final Cerium Oxide (CeO2)-loaded nanotherapeutic system (Rh-ManLP@Ce). In vitro experiments and in vivo model results confirm that Rh-ManLP@Ce exhibits superior responsiveness in high-ROS contexts and is efficiently internalized by macrophages, achieving significant accumulation within atherosclerotic lesions. At the molecular level, the system orchestrates a dual synergistic effect via Rhein inhibiting the inflammatory NF-\u03baB pathway, while the CeO2 concurrently activates the antioxidant Nrf2 pathway. This coordinated action effectively remodels the pathological microenvironment and suppresses foam cell formation, ultimately delaying plaque progression. Consequently, this work presents a robust, precise strategy for managing atherosclerosis, offering broad implications for therapeutic interventions in other diseases driven by oxidative stress and inflammation.<\/jats:p>","DOI":"10.1021\/acsami.6c07257","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:39:17Z","timestamp":1785854357000},"page":"42289-42304","source":"Crossref","is-referenced-by-count":1,"title":["Macrophage-Targeted ROS-Responsive Nanoplatform for Coordinated NF-\u03baB and Nrf2 Modulation in Atherosclerosis Therapy"],"prefix":"10.1021","volume":"18","author":[{"given":"Jin","family":"Liu","sequence":"first","affiliation":[{"name":"Yantai University , , ,","place":["Yantai, P.R. China, 264005"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5283-8253","authenticated-orcid":true,"given":"Bo","family":"Li","sequence":"additional","affiliation":[{"name":"Yantai University , , ,","place":["Yantai, P.R. China, 264005"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Tian","sequence":"additional","affiliation":[{"name":"Yantai University , , ,","place":["Yantai, P.R. China, 264005"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Yantai University , , ,","place":["Yantai, P.R. China, 264005"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Shi","sequence":"additional","affiliation":[{"name":"Yantai University , , ,","place":["Yantai, P.R. China, 264005"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Liu","sequence":"additional","affiliation":[{"name":"Yantai University , , ,","place":["Yantai, P.R. China, 264005"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"issue":"4","key":"2026081706070226400_cit1","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/eurheartj\/ehz001","article-title":"Understanding and preventing atherosclerosis: From bench to bedside","volume":"40","author":"L\u00fcscher","year":"2019","journal-title":"Eur. Heart J."},{"issue":"7855","key":"2026081706070226400_cit2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"key":"2026081706070226400_cit3","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2025.1652933","article-title":"Innovative molecular intervention and precision therapy for atherosclerosis","volume":"12","author":"Wang","year":"2025","journal-title":"Front. Cardiovasc. Med."},{"issue":"27","key":"2026081706070226400_cit4","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1093\/eurheartj\/ehae324","article-title":"Low-dose aspirin for the prevention of atherosclerotic cardiovascular disease","volume":"45","author":"Patrono","year":"2024","journal-title":"Eur. Heart J."},{"key":"2026081706070226400_cit5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173090","article-title":"Macrophage M1\/M2 polarization","volume":"877","author":"Chen","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"2026081706070226400_cit6","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","article-title":"Targeting inflammation in atherosclerosis - from experimental insights to the clinic","volume":"20","author":"Soehnlein","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"22","key":"2026081706070226400_cit7","doi-asserted-by":"publisher","first-page":"22366","DOI":"10.1021\/acsomega.5c01865","article-title":"The role of ROS in atherosclerosis and ROS-based nanotherapeutics for atherosclerosis: Atherosclerotic lesion targeting, ROS scavenging, and ROS-responsive activity","volume":"10","author":"Qian","year":"2025","journal-title":"ACS Omega"},{"key":"2026081706070226400_cit8","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.2147\/IJN.S508757","article-title":"How advanced is nanomedicine for atherosclerosis?","volume":"20","author":"Gu","year":"2025","journal-title":"Int. J. Nanomed."},{"issue":"43","key":"2026081706070226400_cit9","doi-asserted-by":"publisher","first-page":"58072","DOI":"10.1021\/acsami.4c13607","article-title":"Advanced applications of nanomaterials in atherosclerosis diagnosis and treatment: challenges and future prospects","volume":"16","author":"Tong","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"8","key":"2026081706070226400_cit10","doi-asserted-by":"publisher","first-page":"11443","DOI":"10.1021\/acsami.4c15165","article-title":"Recent advances in micro\/nanomotor for the therapy and diagnosis of atherosclerosis","volume":"17","author":"Qin","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"39","key":"2026081706070226400_cit11","doi-asserted-by":"publisher","first-page":"51944","DOI":"10.1021\/acsami.4c08671","article-title":"Novel metal-free nanozyme for targeted imaging and inhibition of atherosclerosis via macrophage autophagy activation to prevent vulnerable plaque formation and rupture","volume":"16","author":"Wang","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"23","key":"2026081706070226400_cit12","doi-asserted-by":"publisher","first-page":"32369","DOI":"10.1021\/acsami.6c04973","article-title":"Oral administration of berberine-based carbon dots target ferric iron to alleviate atherosclerosis","volume":"18","author":"Li","year":"2026","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"11","key":"2026081706070226400_cit13","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nrd3578","article-title":"Perspectives and opportunities for nanomedicine in the management of atherosclerosis","volume":"10","author":"Lobatto","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"2026081706070226400_cit14","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1205751","article-title":"Atherosclerosis treatment with nanoagent: potential targets, stimulus signals and drug delivery mechanisms","volume":"11","author":"Luo","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"2","key":"2026081706070226400_cit15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"5","key":"2026081706070226400_cit16","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202202416","article-title":"Hyaluronic acid-guided cerasome nano-agents for simultaneous imaging and treatment of advanced atherosclerosis","volume":"10","author":"Ma","year":"2023","journal-title":"Adv. Sci."},{"issue":"1","key":"2026081706070226400_cit17","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/s12951-021-01084-z","article-title":"Targeted theranostic photoactivation on atherosclerosis","volume":"19","author":"Song","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"15","key":"2026081706070226400_cit18","doi-asserted-by":"publisher","first-page":"14555","DOI":"10.1021\/acsnano.3c01420","article-title":"Design of a multifunctional nanozyme for resolving the proinflammatory plaque microenvironment and attenuating atherosclerosis","volume":"17","author":"He","year":"2023","journal-title":"ACS Nano"},{"issue":"1","key":"2026081706070226400_cit19","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1186\/s12951-024-02652-9","article-title":"Targeted nanoparticles triggered by plaque microenvironment for atherosclerosis treatment through cascade effects of reactive oxygen species scavenging and anti-inflammation","volume":"22","author":"Luo","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"34","key":"2026081706070226400_cit20","doi-asserted-by":"publisher","first-page":"23599","DOI":"10.1021\/acsnano.4c07988","article-title":"Reactive oxygen species-responsive nanoparticle delivery of small interfering ribonucleic acid targeting olfactory receptor 2 for atherosclerosis theranostics","volume":"18","author":"Ni","year":"2024","journal-title":"ACS Nano"},{"issue":"10","key":"2026081706070226400_cit21","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.3390\/antiox11101958","article-title":"Roles of oxidative stress and inflammation in vascular endothelial dysfunction-related disease","volume":"11","author":"Higashi","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"2026081706070226400_cit22","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110433","article-title":"Targeting foam cell formation and macrophage polarization in atherosclerosis: The therapeutic potential of rhubarb","volume":"129","author":"Liu","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"2026081706070226400_cit23","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.3390\/ph17121665","article-title":"Rhein: An updated review concerning its biological activity, pharmacokinetics, structure optimization, and future pharmaceutical applications","volume":"17","author":"Fu","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"1","key":"2026081706070226400_cit24","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1186\/s12951-025-03775-3","article-title":"Electron-injected Pd@CeO2 nanozymes for multifaceted ROS scavenging and protection against ischemia-reperfusion injury in skin flaps","volume":"23","author":"Zhou","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"3","key":"2026081706070226400_cit25","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1038\/am.2013.88","article-title":"Cerium oxide nanoparticle: A remarkably versatile rare earth nanomaterial for biological applications","volume":"6","author":"Xu","year":"2014","journal-title":"NPG Asia Mater."},{"key":"2026081706070226400_cit26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121686","article-title":"Ceria nanoparticles prophylactic used for renal ischemia-reperfusion injury treatment by attenuating oxidative stress and inflammatory response","volume":"287","author":"Zhou","year":"2022","journal-title":"Biomaterials"},{"key":"2026081706070226400_cit27","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2025.106022","article-title":"An interdisciplinary approach to assessing the toxicity reduction of cerium oxide nanoparticles coated with polyethylene glycol and polyvinylpyrrolidone polymers: An in vitro study","volume":"105","author":"Soltani","year":"2025","journal-title":"Toxicol. In Vitro"},{"key":"2026081706070226400_cit28","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.845942","article-title":"Foam cells in atherosclerosis: Novel insights into its origins, consequences, and molecular mechanisms","volume":"9","author":"Gui","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"2026081706070226400_cit29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1215612","article-title":"Macrophage death in atherosclerosis: Potential role in calcification","volume":"14","author":"Neels","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"2026081706070226400_cit30","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1186\/s12951-024-02939-x","article-title":"Macrophage membrane-functionalized manganese dioxide nanomedicine for synergistic treatment of atherosclerosis by mitigating inflammatory storms and promoting cholesterol efflux","volume":"22","author":"Chen","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"7","key":"2026081706070226400_cit31","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2026081706070226400_cit32","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2795090","article-title":"The reactive oxygen species in macrophage polarization: Reflecting its dual role in progression and treatment of human diseases","volume":"2016","author":"Tan","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"2026081706070226400_cit33","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103229","article-title":"Activation of Nrf2 inhibits atherosclerosis in ApoE-\/- mice through suppressing endothelial cell inflammation and lipid peroxidation","volume":"74","author":"He","year":"2024","journal-title":"Redox Biol."},{"issue":"22","key":"2026081706070226400_cit34","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.3390\/molecules25225474","article-title":"An overview of Nrf2 signaling pathway and its role in inflammation","volume":"25","author":"Saha","year":"2020","journal-title":"Molecules"},{"key":"2026081706070226400_cit35","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2023.117312","article-title":"Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook","volume":"383","author":"Raja","year":"2023","journal-title":"Atherosclerosis"},{"issue":"12","key":"2026081706070226400_cit36","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1172\/JCI38911","article-title":"LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression","volume":"120","author":"Feig","year":"2010","journal-title":"J. Clin. Invest."},{"key":"2026081706070226400_cit37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fcvm.2018.00032","article-title":"Insights from pre-clinical and clinical studies on the role of innate inflammation in atherosclerosis regression","volume":"5","author":"Rahman","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"key":"2026081706070226400_cit38","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2024.1473709","article-title":"Mechanistic insights into the regression of atherosclerotic plaques","volume":"15","author":"Song","year":"2024","journal-title":"Front. Physiol."},{"issue":"8","key":"2026081706070226400_cit39","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1172\/JCI75005","article-title":"Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression","volume":"127","author":"Rahman","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"22","key":"2026081706070226400_cit40","doi-asserted-by":"publisher","first-page":"12017","DOI":"10.3390\/ijms252212017","article-title":"Vascular extracellular matrix in atherosclerosis","volume":"25","author":"Di Nubila","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"2026081706070226400_cit41","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107833","article-title":"VSMCs in atherosclerosis: Implications on the role of inflammation and extracellular matrix remodelling","volume":"218","author":"Jarad","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"9","key":"2026081706070226400_cit42","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1161\/ATVBAHA.123.318237","article-title":"Extracellular matrix remodeling in vascular disease: defining its regulators and pathological influence","volume":"43","author":"Lin","year":"2023","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"2026081706070226400_cit43","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1093\/cvr\/cvad079","article-title":"Transforming growth factor-\u03b22 is associated with atherosclerotic plaque stability and lower risk for cardiovascular events","volume":"119","author":"Edsfeldt","year":"2023","journal-title":"Cardiovasc. Res."},{"issue":"21","key":"2026081706070226400_cit44","doi-asserted-by":"publisher","first-page":"12964","DOI":"10.3390\/ijms232112964","article-title":"Non-mouse models of atherosclerosis: Approaches to exploring the translational potential of new therapies","volume":"23","author":"Kamato","year":"2022","journal-title":"Int. J. Mol. Sci."}],"container-title":["ACS Applied Materials &amp; Interfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsami.6c07257","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/aamick\/article-pdf\/18\/31\/42289\/66365224\/am-2026-07257k.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/aamick\/article-pdf\/18\/31\/42289\/66365224\/am-2026-07257k.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T10:28:22Z","timestamp":1786962502000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/aamick\/article\/18\/31\/42289\/5239445\/Macrophage-Targeted-ROS-Responsive-Nanoplatform"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":44,"journal-issue":{"issue":"31","published-online":{"date-parts":[[2026,8,3]]},"published-print":{"date-parts":[[2026,8,12]]}},"URL":"https:\/\/doi.org\/10.1021\/acsami.6c07257","relation":{},"ISSN":["1944-8244","1944-8252"],"issn-type":[{"value":"1944-8244","type":"print"},{"value":"1944-8252","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]}}}